CALR and neoplasm: found that calreticulin exposure increases the aggregation of CD11c+CD14+ marrow cell populations in tumor microenvironment, thereby enhancing the phagocytic and cytotoxic effects of natural killer (NK) cells on acute myeloid leukemia cells (39).